Assignment:
You are the CEO of a biotech research company. Since startup three years ago, you and a staff of five highly qualified researchers have developed a new drug that shows great promise in combating resistant strains of malaria. The intellectual property rights to the drug have been licensed to a large pharmaceutical company. Under the licensing agreement, your firm will receive an upfront payment of $5 million plus a minimum of $1 million a year for the next ten years or a share of the pharmaceutical company's revenues from the drug, whichever is greater.
Since starting this company you have discovered that you have rather good managerial skills and a hunger for building and growing new businesses. Bearing in mind the resources that are currently available to your company, what are your strategic options at this point? What are the strengths and weaknesses of your organization? Think in terms of new products, new markets, and potential strategic partners. Consider also what new resources and competencies you might wish to develop.
Your answer must be typed, double-spaced, Times New Roman font (size 12), one-inch margins on all sides, APA format and also include references.